Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK – Get Rating) was the target of a significant growth in short interest in December. As of December 30th, there was short interest totalling 10,300 shares, a growth of 1,371.4% from the December 15th total of 700 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily volume of 54,500 shares, the short-interest ratio is presently 0.2 days.

Arbor Rapha Capital Bioholdings Corp. I Price Performance

NASDAQ ARCK opened at $11.90 on Tuesday. Arbor Rapha Capital Bioholdings Corp. I has a 52-week low of $9.93 and a 52-week high of $15.59. The business's 50-day moving average price is $10.90 and its 200 day moving average price is $10.39.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Elequin Capital LP bought a new stake in Arbor Rapha Capital Bioholdings Corp. I during the third quarter worth approximately $25,000. Robinson Capital Management LLC bought a new position in shares of Arbor Rapha Capital Bioholdings Corp. I during the 2nd quarter valued at $205,000. Landscape Capital Management L.L.C. bought a new position in shares of Arbor Rapha Capital Bioholdings Corp. I during the 3rd quarter valued at $214,000. Glazer Capital LLC acquired a new position in Arbor Rapha Capital Bioholdings Corp. I in the 1st quarter valued at $470,000. Finally, Mint Tower Capital Management B.V. acquired a new position in Arbor Rapha Capital Bioholdings Corp. I in the 3rd quarter valued at $818,000. 68.70% of the stock is currently owned by institutional investors.

About Arbor Rapha Capital Bioholdings Corp. I

Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector.

See Also

• Get a free copy of the StockNews.com research report on Arbor Rapha Capital Bioholdings Corp. I (ARCK)
• 3 Dividend Stocks For Passive Income
• UnitedHealth Group Stock: Is This The Bottom?
• Tesla Stock Continues To Consolidate After A Bad Quarter
• Is Visa Stock About To Hit An All Time High?
• 2 Hot Stocks The Insiders Are Buying

Receive News & Ratings for Arbor Rapha Capital Bioholdings Corp. I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbor Rapha Capital Bioholdings Corp. I and related companies with MarketBeat.com's FREE daily email newsletter.